Asia Deal Watch: Oxford Biomedica's First Japanese Partnership Focuses On Rare Retinal Disorder - Scrip

Asia Deal Watch: Oxford Biomedica's First Japanese Partnership Focuses On Rare Retinal Disorder  Scrip

Oxford Biomedica is teaming with Santen to develop a gene therapy for an undisclosed eye disease. Shionogi inks a pair of partnerships for Chinese rights to ...